Career Opportunities
暂无分享,去创建一个
[1] C. Heldin,et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. , 1992, Cancer research.
[2] M. Israel,et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. , 2002, Cancer research.
[3] J. Debus,et al. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells , 2006, BMC Cancer.
[4] Fabian Kiessling,et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis , 2005, The Journal of experimental medicine.
[5] A B West,et al. Myofibroblasts: paracrine cells important in health and disease. , 2000, Transactions of the American Clinical and Climatological Association.
[6] G. Silvestri,et al. Pulmonary complications of radiation therapy. , 2004, Clinics in chest medicine.
[7] B. Westermark,et al. A platelet factor stimulating human normal glial cells. , 1976, Experimental cell research.
[8] J. Lasky,et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. , 1999, The American journal of pathology.
[9] LP Nicod. Pirfenidone in idiopathic pulmonary fibrosis , 1999, The Lancet.
[10] J. Lasky,et al. Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[11] M. Versnel,et al. Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity , 2003, European Respiratory Journal.
[12] D. Morgan,et al. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. , 1999, The American journal of pathology.
[13] R H Dean,et al. Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. , 1997, Circulation research.
[14] R. Ross,et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[15] Peter Vajkoczy,et al. Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] P. Phillips,et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.
[17] C. Heldin,et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. , 2001, Nature cell biology.
[18] H. Herbst,et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.
[19] J. Hendry,et al. Normal tissue radiobiology: from the laboratory to the clinic. , 2001, International journal of radiation oncology, biology, physics.
[20] B. Meyrick,et al. Early structural changes in sheep lung following thoracic irradiation. , 1988, Radiation research.
[21] C. Betsholtz,et al. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.
[22] J. Schlessinger,et al. How receptor tyrosine kinases activate Ras. , 1993, Trends in biochemical sciences.
[23] Fabian Kiessling,et al. Computed Tomography Monitoring of Radiation-Induced Lung Fibrosis in Mice , 2004, Investigative radiology.
[24] G. Gurujeyalakshmi,et al. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[25] C. Heldin. Simultaneous induction of stimulatory and inhibitory signals by PDGF , 1997, FEBS letters.
[26] W Budach,et al. Impact of stromal sensitivity on radiation response of tumors. , 1993, Journal of the National Cancer Institute.
[27] R. Motzer,et al. Sunitinib in patients with metastatic renal cell carcinoma. , 2006, JAMA.
[28] H. Kantarjian,et al. Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-α , 2004 .
[29] C. Heldin,et al. Isoform‐specific induction of actin reorganization by platelet‐derived growth factor suggests that the functionally active receptor is a dimer. , 1989, The EMBO journal.
[30] C. Belka,et al. Irradiation-induced pneumonitis mediated by the CD95/CD95-ligand system. , 2006, Journal of the National Cancer Institute.
[31] M. Wills-Karp,et al. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin. , 2001, American journal of respiratory cell and molecular biology.
[32] Andrius Kazlauskas,et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.
[33] H Li,et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. , 2000, Nature cell biology.
[34] A B West,et al. Myofibroblasts. I. Paracrine cells important in health and disease. , 1999, The American journal of physiology.
[35] Dirk Strumberg,et al. Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment. , 2005, Drugs of today.
[36] T. Colby,et al. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] H. Moses,et al. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[38] Y. Kaneda,et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Ling,et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. , 2000, Cancer journal.
[40] A. Gown,et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[41] K. Nakamura,et al. Beneficial effects of a novel inhibitor of platelet-derived growth factor receptor autophosphorylation in the rat with mesangial proliferative glomerulonephritis. , 1998, General pharmacology.
[42] J. Lasky,et al. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. , 1997, American journal of respiratory cell and molecular biology.
[43] D. Kamp. Idiopathic pulmonary fibrosis: the inflammation hypothesis revisited. , 2003, Chest.
[44] B. Melichar,et al. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy. , 2005, Internal medicine.
[45] R. Fahlbusch,et al. Autocrine control of human meningioma proliferation: Secretion of platelet‐derived growth‐factor‐like molecules , 1991, International journal of cancer.
[46] C. Heldin,et al. Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.
[47] M. Selman,et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. , 1990, The Journal of clinical investigation.
[48] E. Canalis. Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. , 1981, Metabolism: clinical and experimental.
[49] E. Taskinen,et al. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy , 2003, Transplantation.
[50] A. Brody,et al. Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. , 1993, The Journal of clinical investigation.
[51] D. Hanahan,et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.
[52] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[53] Kathleen M. Smith,et al. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.
[54] S. Holgate,et al. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[55] T. Sjöblom,et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. , 2003, The American journal of pathology.
[56] C. Heldin,et al. Platelet-derived growth factor is angiogenic in vivo. , 1992, Growth factors.
[57] E. Holland,et al. Platelet-derived growth factor (PDGF) and glial tumorigenesis. , 2006, Cancer letters.
[58] M. Riad,et al. Aggressive fibromatosis of the head and neck (desmoid tumours) , 2001, The Journal of Laryngology & Otology.
[59] Álvaro R. Osornio-Vargas,et al. Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts. , 1995, American journal of respiratory cell and molecular biology.
[60] T. Libermann,et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.
[61] J. Folkman,et al. Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.
[62] F. DeMayo,et al. Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? , 2002, American journal of physiology. Lung cellular and molecular physiology.
[63] C. Pisano,et al. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity. , 2005, Cancer research.
[64] D. Pérol,et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results. , 2000, International journal of radiation oncology, biology, physics.
[65] R. Ross,et al. Purification of human platelet-derived growth factor. , 1985, Methods in enzymology.
[66] A. Guha,et al. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop , 1995, International journal of cancer.
[67] H. Hammes,et al. Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy , 2002, The EMBO journal.
[68] Samuel Singer,et al. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.
[69] R. Fahlbusch,et al. Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. , 1993, Journal of neurosurgery.
[70] C. Heldin,et al. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. , 1989, The Biochemical journal.
[71] Randall K Ten Haken,et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. , 2006, International journal of radiation oncology, biology, physics.
[72] E. Schönherr,et al. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.
[73] M. Pazin,et al. A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses. , 1991, The Journal of biological chemistry.
[74] D. Morgan,et al. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. , 1997, American journal of respiratory cell and molecular biology.
[75] S. McDonald,et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. , 1995, International journal of radiation oncology, biology, physics.
[76] S. Sone,et al. Increased Binding and Chemotactic Capacities of PDGF-BB on Fibroblasts in Radiation Pneumonitis , 2003, Radiation research.
[77] B. Dörken,et al. Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. , 2005, Blood cells, molecules & diseases.
[78] K. Trott,et al. Target cells in radiation pneumopathy. , 2004, International journal of radiation oncology, biology, physics.
[79] J. Rapp. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1993 .
[80] J. Debus,et al. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. , 2003, Cancer research.
[81] C. Heldin,et al. Platelet-derived growth factor: purification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[82] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[83] P. Kanakaraj,et al. Ligand-induced interaction between alpha- and beta-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation. , 1991, Biochemistry.
[84] D. Hallahan,et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. , 2001, Cancer research.
[85] J. Fletcher,et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] W. Risau,et al. Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro , 1987, The Journal of cell biology.
[87] W. McBride,et al. Cytokine cascades in late normal tissue radiation responses. , 1995, International journal of radiation oncology, biology, physics.
[88] C. Heldin,et al. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. , 1990, The Journal of clinical investigation.
[89] P. Rubin,et al. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. , 1996, Radiation research.